Could Hexo Corp (TSX:HEXO) Be in Trouble With Regulators As Well?

A recent report by a short-seller suggests that Hexo Corp (TSX:HEXO)(NYSE:HEXO) might be the next cannabis stock to run into issues with Health Canada.

| More on:
Businessmen teamwork brainstorming meeting.

Image source: Getty Images

There’s a lot of fear in the cannabis industry in the wake of the CannTrust Holdings scandal. Issues relating to illegal growing there came out of nowhere and sent the stock crashing in just a matter of days.

Then came the news that cannabis giant Curaleaf Holdings in the U.S. was also getting into trouble with the Food and Drug Administration for making some aggressive claims.

These issues have caused a great deal of panic in the industry, and many pot stocks have been struggling over the past month as a result.

One company that’s recently been the target of one short-seller is Hexo Corp (TSX:HEXO)(NYSE:HEXO).

A recent report from The Friendly Bear claims that promotions run by the cannabis operator on Snapchat were “aggressive,” suggesting that they could also run afoul with Health Canada. Using Snapchat is also popular among kids, and if true, that could lead to problems for Hexo.

Could Hexo be the next CannTrust?

The short-seller believes that Hexo could follow in the footsteps of CannTrust, losing a significant amount of its value as a result of the infraction.

However, it should be noted that what CannTrust is accused of doing is illegally growing marijuana, which is on a much different scale than simply promoting their products too aggressively or through the wrong channels.

In Hexo’s situation, products wouldn’t have to be held back to be tested to ensure they’re in compliance with regulations. The company also isn’t being alleged to have misled regulators with respect to how much cannabis it is producing and putting up fake walls to conceal its operations.

Compared to the CannTrust scandal, Hexo is a drop in the bucket. After all, advertisers pushing the limits happens in many industries, not just cannabis; suggesting that Hexo might see a similar drop in share price might therefore be an exaggeration, to say the least.

Health Canada hasn’t indicated the existence of any problems involving Hexo. While it can be unnerving for investors of Hexo, ultimately this is just speculation by a short-seller.

We don’t know whether these claims are valid, and so any concerns surrounding the company may be all for naught. The problem, however, is that if there was confirmation that Hexo was in violation of rules relating to advertising, the stock could go into a free fall very quickly.

Bottom line

It’s a very risky time to be a cannabis investor. Everyone is on the lookout for which company could be the next one to run into regulatory issues, which means that even claims made by a short-seller could send investors into a panic.

The problem is that if investors don’t act on the claims early enough, they could suffer more significant losses if the violations are confirmed to be true. However, if prove to be unfounded, the stock could get a big boost in price.

There’s no way to know for sure — which is making investing in cannabis stocks even riskier today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »